Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Achillion Appoints CSO

This article was originally published in Scrip

Executive Summary

Achillion Pharmaceuticals has appointed Joel Barrish chief scientific officer and executive vice president – effective Jan. 4, 2016. Barrish has over 30 years' experience in the pharmaceutical industry and most recently was vice president and head of discovery chemistry at Bristol-Myers Squibb (BMS). He has also co-authored more than 120 peer-reviewed publications.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register